Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132762) titled 'Clinical Application Study of 18F/68Ga/64Cu-TROP2 PET Examination in Tumor with High Expression of TROP2' on Sept. 18.
Study Type: Diagnostic test
Study Design:
Diagnostic test for accuracy
Primary Sponsor: Shanghai Tenth People's Hospital
Condition:
Tumor with high expression of trophoblast cell surface antigen 2 (TROP2), such as breast cancer, non-small cell lung cancer, colorectal cancer, urothelial carcinoma, prostate cancer, etc.
Intervention:
Gold Standard:Detection of TROP2 expression by pathological IHC method
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-09-18 ...